🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Moderate intensity titrated dose anticoagulation has been used in patients ...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2022-05-12
Trial ID
NCT04997265
Treatments Being Tested
The optimal intensity of oral anticoagulation in China patients undergoing ...
Status
Completed
Location
WAHH
Start Date
2013-01
Trial ID
NCT01996657
Treatments Being Tested
The purpose of this trial is to demonstrate the efficacy and safety of dabi...
Status
Unknown
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2016-03
Trial ID
NCT02646267
Treatments Being Tested
Current guidelines recommend standard warfarin anticoagulation internationa...
Status
Completed
Location
First Affiliated Hospital of Nanjing Medical University, Division of Geriatrics
Start Date
2010-01
Trial ID
NCT01438580
The TARGET trial is a prospective, single-center, randomized, open-label, a...
Status
Not Yet Recruiting
Location
Asan Medical Center, University of Ulsan College of Medicine
Start Date
2025-10
Trial ID
NCT07081035
Treatments Being Tested
The purpose of this study is to obtain single-center safety and feasibility...
Status
Unknown
Location
Multiple Locations
Start Date
2017-01-11
Trial ID
NCT03078374
Treatments Being Tested
Design: U.S.-based, single-center, randomized placebo-controlled trial. Br...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2021-03-01
Trial ID
NCT04168203
Treatments Being Tested
ECMO is widely used in patients with refractory respiratory and/or circulat...
Status
Recruiting
Location
Bing Sun
Start Date
2024-11-01
Trial ID
NCT06676085
Treatments Being Tested
The goal of this registry is to gather more information on the efficacy and...
Status
Recruiting
Location
Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires
Start Date
2022-07-01
Trial ID
NCT05646394